(Q71683517)
Statements
Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice (English)
Motoki K
Maeda K
Ueno H
Kobayashi E
Uchida T
Fukushima H